“…Meanwhile, the proportion of fluorine-containing pharmaceuticals in commercial pharmaceuticals has exceeded 20% . However, pharmaceuticals with gem -difluoroallylic moieties, such as Glecaprevir, Tafluprost, and so forth, − accounted for a very low proportion in known fluorine-containing pharmaceuticals, which was related to the lack of efficient synthetic approaches for such construction. , Several recent studies have focused on the synthesis of functionalized Z -allylic building blocks with gem -difluoromethylene motifs, which will undoubtedly speed up and facilitate the construction of pharmaceutically interesting molecules and advanced materials. − However, the methods to access these specific skeletons are mainly finite to the semihydrogenation and diverse cross-coupling of relatives with organometallics under certain conditions (Scheme a) . Inherently, all of these strategies rely on kinetic controls and the use of specific reagents. − On the other hand, photoredox catalysis with various photosensitizers has played an important role and been recognized as an efficient green process and stimulated numerous contributions of advances for the C–C bond coupling in organic synthesis in the past 2 decades. − Nevertheless, not many successful cases of the photo-induced electron transfer (PET) process for the construction of organofluorine molecules have been reported yet (Scheme b,c). , …”